⸺ Celvora
R3ta Pre-filled Pen (Alluvi)
Alluvi Healthcare R3ta supplied as a ready-to-use pre-filled pen — triple agonist of GLP-1, GIP and glucagon receptors. Research use only.
Size
Secure checkout. Free shipping on orders over £100.
Independently tested
COA on request
Fast dispatch
Order before 2pm
Research use only
Not for human consumption
⸺ Overview
About R3ta Pre-filled Pen (Alluvi)
A pre-filled pen presentation of R3ta by Alluvi Healthcare. Ready-to-use — no reconstitution required.
⸺ Mechanism of Action
How it works
R3ta simultaneously activates the GLP-1, GIP and glucagon receptors, driving glucose-dependent insulin release, slowed gastric emptying and modified energy handling in animal models.
⸺ Research
Areas of study
Triple-receptor metabolic studies
Preclinical models report integrated effects on appetite, energy expenditure and glycaemic control.
Body composition in rodents
Animal research describes reductions in fat mass under sustained R3ta dosing.
⸺ Details
Specification
- CAS
- 2381089-83-2
- Intended use
- Research use only. Pre-filled pen.
- Storage
- Refrigerate 2–8°C, keep in carton away from light.
- Solubility
- Pre-filled solution. No reconstitution required.
- Shelf life
- Refer to printed expiry.
- Handling
- Sterile technique.
You might also research
View all →
R3ta
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied for appetite control, energy expenditure and glucose balance.
T1rz
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.